Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice

被引:115
作者
Xiong, Wen-Ting [1 ]
Gu, Li [1 ]
Wang, Chao [1 ]
Sun, Hong-Xia [1 ]
Liu, Xin [1 ]
机构
[1] Sun Yat Sen Univ, Sch Life Sci, State Educ Minist, Food & Hlth Engn Res Ctr, Guangzhou 510275, Guangdong, Peoples R China
关键词
Cistanche tubulosa; Type; 2; diabetes; Anti-hyperglycemic effect; Hypolipidemic effect; FASTING PLASMA-GLUCOSE; ANTIOXIDANT CAPACITY; PHENOLIC-COMPOUNDS; MANAGEMENT; HEALTH; OBESE; CONSTITUENTS; VERBASCOSIDE; PATHOGENESIS; HOMEOSTASIS;
D O I
10.1016/j.jep.2013.09.027
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: The dried succulent stem of Cistanche tubulosa (Schenk) R. Wight is one component of traditional Chinese medicine prescriptions for diabetes. However, there have been no modern scientific reports to confirm this traditional claim for the Cistanche species until now. Thus, we investigated the effects of Cistanche tubulosa on glucose homeostasis and serum lipids in male BKS. Cg-Dock7(m) +/+ Lepr(db)/J (db/db) mice, a model of type 2 diabetes. Materials and methods: The verbascoside and echinacoside contents of Cistanche tubulosa powder were evaluated using HPLC. The total phenolic content, polysaccharide content and antioxidant activity of Cistanche tubulosa powder were also evaluated. Then, different doses of Cistanche tubulosa (equivalent to 120.9, 72.6 or 24.2 mg verbascoside/kg) were administered orally once daily for 45 days to male db/db mice. Age matched db/+ mice were used as normal controls. Body weight, fasting blood glucose, postprandial blood glucose and insulin tolerance test were measured during the experiment. At the time of sacrifice, blood was collected for measurement of insulin level, the homeostatic model assessment of insulin resistance (HOMA-IR), and total cholesterol, triglyceride, HDL-c, LDL-c and VLDL-c levels; liver and muscle were harvested for measurement of glycogen levels. Results: Cistanche tubulosa significantly suppressed the elevated fasting blood glucose and postprandial blood glucose levels, improved insulin resistance and dyslipidemia, and suppressed body weight loss in db/db mice. However, Cistanche tubulosa did not significantly affect serum insulin levels or hepatic and muscle glycogen levels. Conclusion: This study provides scientific evidence for the traditional use of Cistanche tubulosa to treat diabetes, suggesting that Cistanche tubulosa has the potential for development into a functional food ingredient or drug to prevent hyperglycemia and treat hyperlipidemia. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:935 / 945
页数:11
相关论文
共 50 条
  • [41] Fermentation with Aquilariae Lignum Enhances the Anti-Diabetic Activity of Green Tea in Type II Diabetic db/db Mouse
    Kang, Su Jin
    Lee, Ji Eun
    Lee, Eun Kyung
    Jung, Dae Hwa
    Song, Chang Hyun
    Park, Soo Jin
    Choi, Seong Hun
    Han, Chang Hyun
    Ku, Sae Kwang
    Lee, Young Joon
    NUTRIENTS, 2014, 6 (09) : 3536 - 3571
  • [42] Type 2 Diabetes Leads to Axon Initial Segment Shortening in db/db Mice
    Yermakov, Leonid M.
    Drouet, Domenica E.
    Griggs, Ryan B.
    Elased, Khalid M.
    Susuki, Keiichiro
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [43] Anti-Diabetic Effects of Allium hookeri Extracts Prepared by Different Methods in Type 2 C57BL/J-db/db Mice
    Choi, Ji-Hye
    Kim, Si-Hyun
    Lee, Eun-Byeol
    Kim, Ji-Su
    Jung, Ji-Eeun
    Jeong, Un-Yul
    Kim, Ju-Hui
    Jang, Hwan-Hee
    Park, Shin-Young
    Kim, Gi-Chang
    Lim, Jung-Hyun
    Lee, Sung-Hyen
    PHARMACEUTICALS, 2022, 15 (04)
  • [44] Functional and morphological alterations of the urinary bladder in type 2 diabetic FVBdb/db mice
    Wu, Liyang
    Zhang, Xiaodong
    Xiao, Nan
    Huang, Yexiang
    Kavran, Michael
    Elrashidy, Rania A.
    Wang, Mingshuai
    Daneshgari, Firouz
    Liu, Guiming
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (05) : 778 - 785
  • [45] Anti-hyperglycemic and hypolipidemic effects of Saraca asoca (Roxb.) Wild. flowers in alloxan-treated diabetic rats
    Thilagam, Ellappan
    Chidambaram, Kumarappan
    Raviteja, Chinthamreddy
    Vahana, Thalu
    Vasudevan, Parameshwaran
    JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2021, 9 (01): : 58 - 68
  • [46] Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice
    Zhang, Yu
    Li, Yufeng
    Zhao, Junjun
    Wang, Cong
    Deng, Bin
    Zhang, Qilin
    Shi, Chen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?
    Majumdar, Sachin K.
    Inzucchi, Silvio E.
    ENDOCRINE, 2013, 44 (01) : 47 - 58
  • [48] Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy
    Ninichuk, V.
    Kulkarni, O.
    Clauss, S.
    Anders, H.-J.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (08) : 351 - 355
  • [49] Therapeutic potential of buckwheat hull flavonoids in db/db mice, a model of type 2 diabetes
    Li, Pengcheng
    Tang, Yufang
    Liu, Liming
    Wang, Dan
    Zhang, Lan
    Piao, Chunhong
    JOURNAL OF FUNCTIONAL FOODS, 2019, 52 : 284 - 290
  • [50] Hypolipidemic and Antidiabetic Effects of Functional Rice Cookies in High-Fat Diet-Fed ICR Mice and db/db Mice
    Hong, Sun Hee
    Woo, Minji
    Kim, Mijeong
    Song, Yeong Ok
    JOURNAL OF MEDICINAL FOOD, 2018, 21 (06) : 535 - 543